Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which ...
Joint Korea-Japan research finds no evidence linking mobile phone radio frequency exposure to cancer
Yong-Bum Kim, principal researcher at the Korea Institute of Toxicology (KIT), who oversaw the long-term exposure study and pathological analysis, said the pathological evaluation ensured objectivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results